Xu Wei, Zhao Haiguang
Department of Plastic Surgery, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, Shandong, China.
Front Oncol. 2022 Nov 29;12:1064048. doi: 10.3389/fonc.2022.1064048. eCollection 2022.
Infantile hemangiomas (IHs) are benign vascular tumors commonly observed in children. A small number of cases can manifest as organ or system dysfunction, permanent scarring, or even disfigurement. Currently, diagnosis is mainly based on clinical history, physical examination, and auxiliary inspection. In the treatment of a hemangioma, the functional damage caused by the lesion and complications that may endanger the patient's life should be given priority. This suggests that identification, diagnosis, and referral to specialists during the early stages of IHs are important factors in preventing related complications and obtaining a better prognosis. During the past few decades, researchers have explored different treatments according to the condition, including oral or topical drugs, topical drug injections, laser surgery, and surgical treatment. However, oral propranolol remains a well-accepted first-line treatment. This article will primarily focus on the recent advances in the clinical diagnosis and treatment of hemangiomas, along with a literature review on the subject.
婴儿血管瘤（IHs）是儿童常见的良性血管肿瘤。少数病例可表现为器官或系统功能障碍、永久性瘢痕，甚至毁容。目前，诊断主要基于临床病史、体格检查和辅助检查。在血管瘤的治疗中，应优先考虑病变引起的功能损害以及可能危及患者生命的并发症。这表明在婴儿血管瘤的早期阶段进行识别、诊断并转诊至专科医生是预防相关并发症并获得更好预后的重要因素。在过去几十年中，研究人员根据病情探索了不同的治疗方法，包括口服或外用药物、局部药物注射、激光手术和手术治疗。然而，口服普萘洛尔仍然是广泛接受的一线治疗方法。本文将主要关注血管瘤临床诊断和治疗的最新进展，并对该主题进行文献综述。
